Literature DB >> 20981128

Clinical utility of image-guided peritoneal and omental biopsy.

John A Spencer1, Michael J Weston, Samir A Saidi, Nafisa Wilkinson, Geoffrey D Hall.   

Abstract

Image-guided core biopsy of the omentum and peritoneum was described a decade ago and has since been validated in a number of large studies as a safe and effective means of providing a tissue diagnosis in patients with undiagnosed peritoneal disease. Some studies have addressed its ability for determining whether peritoneal infiltration and/or omental masses in patients with prior malignancy represent recurrent disease or a new disease process. Others have focused on the specific issue of women suspected to have advanced peritoneal carcinomatosis from ovarian or primary peritoneal cancer where the primary management of the patient is directed by the tissue diagnosis. The initial management of many of these women, especially those with advanced disease or substantial comorbidity, is with primary chemotherapy. With current clinical trials for ovarian cancer directed to specific morphological subtypes of the disease, image-guided core biopsy offers a rapid and well tolerated nonsurgical means of providing this information. In this Review, we discuss the technique and its clinical applications, and critically examine the currently available alternative options.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20981128     DOI: 10.1038/nrclinonc.2010.155

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


  36 in total

Review 1.  Application of immunohistochemistry to cytology.

Authors:  Larry J Fowler; Whitney A Lachar
Journal:  Arch Pathol Lab Med       Date:  2008-03       Impact factor: 5.534

2.  An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.

Authors:  Ciaran J O'Neill; Michael T Deavers; Anais Malpica; Heather Foster; W Glenn McCluggage
Journal:  Am J Surg Pathol       Date:  2005-08       Impact factor: 6.394

3.  A review of 50 consecutive cytology cell block preparations in a large general hospital.

Authors:  F Mayall; B Chang; A Darlington
Journal:  J Clin Pathol       Date:  1997-12       Impact factor: 3.411

4.  Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

Authors:  Noah D Kauff; Jaya M Satagopan; Mark E Robson; Lauren Scheuer; Martee Hensley; Clifford A Hudis; Nathan A Ellis; Jeff Boyd; Patrick I Borgen; Richard R Barakat; Larry Norton; Mercedes Castiel; Khedoudja Nafa; Kenneth Offit
Journal:  N Engl J Med       Date:  2002-05-20       Impact factor: 91.245

5.  Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease.

Authors:  June Y Hou; Michael G Kelly; Herbert Yu; Jessica N McAlpine; Masoud Azodi; Thomas J Rutherford; Peter E Schwartz
Journal:  Gynecol Oncol       Date:  2007-01-18       Impact factor: 5.482

6.  High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour.

Authors:  C J O'Neill; H A McBride; L E Connolly; M T Deavers; A Malpica; W G McCluggage
Journal:  Histopathology       Date:  2007-05       Impact factor: 5.087

7.  Image-guided biopsy in patients with suspected ovarian carcinoma: a safe and effective technique?

Authors:  Nyree Griffin; Lee A Grant; Susan J Freeman; Mercedes Jimenez-Linan; Laurence H Berman; Helena Earl; Ahmed Ashour Ahmed; Robin Crawford; James Brenton; Evis Sala
Journal:  Eur Radiol       Date:  2008-08-15       Impact factor: 5.315

8.  Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis?

Authors:  R W Hunter; N D Alexander; W P Soutter
Journal:  Am J Obstet Gynecol       Date:  1992-02       Impact factor: 8.661

9.  International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.

Authors:  J Baptist Trimbos; Mahesh Parmar; Ignace Vergote; David Guthrie; Giorgio Bolis; Nicoletta Colombo; Jan B Vermorken; Valter Torri; Constantino Mangioni; Sergio Pecorelli; Andrea Lissoni; Ann Marie Swart
Journal:  J Natl Cancer Inst       Date:  2003-01-15       Impact factor: 13.506

10.  Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience.

Authors:  Ahmet Bilici; Taflan Salepci; Faysal Dane; Mahmut Gumus; Bala Basak Oven Ustaalioglu; Mesut Seker; Tarik Salman; Cem Turan; Orhan Unal; Mustafa Yaylaci
Journal:  Arch Gynecol Obstet       Date:  2009-12-25       Impact factor: 2.344

View more
  6 in total

1.  Ultrasound Elastography for Differentiating Benign from Malignant Thickened Greater Omentum.

Authors:  Yixia Zhang; Xuemei Wang; Chunmei Tao; Yanhong Que; Wenjing Zhao; Bo Chen
Journal:  Eur Radiol       Date:  2015-09-29       Impact factor: 5.315

2.  Chronic inflammation masquerading as an appendiceal tumour with peritoneal metastasis: the challenge of diagnosis and the lessons learnt.

Authors:  Muhammad Qutayba Almerie; Adam Culverwell; Jyoti Krishna; Christopher Mahon
Journal:  BMJ Case Rep       Date:  2016-02-25

3.  Image-guided interventional radiological delivery of chimeric antigen receptor (CAR) T cells for pleural malignancies in a phase I/II clinical trial.

Authors:  Mario Ghosn; Waseem Cheema; Amy Zhu; Jennifer Livschitz; Majid Maybody; Franz E Boas; Ernesto Santos; DaeHee Kim; Jason A Beattie; Michael Offin; Valerie W Rusch; Marjorie G Zauderer; Prasad S Adusumilli; Stephen B Solomon
Journal:  Lung Cancer       Date:  2022-01-06       Impact factor: 6.081

4.  Ultrasound-Guided Percutaneous Core Needle Biopsy of Abdominal Viscera: Tips to Ensure Safe and Effective Biopsy.

Authors:  Jin Woong Kim; Sang Soo Shin
Journal:  Korean J Radiol       Date:  2017-02-07       Impact factor: 3.500

Review 5.  Extracellular vesicle contents as non-invasive biomarkers in ovarian malignancies.

Authors:  Lindsey A McAlarnen; Prachi Gupta; Reena Singh; Sunila Pradeep; Pradeep Chaluvally-Raghavan
Journal:  Mol Ther Oncolytics       Date:  2022-08-05       Impact factor: 6.311

6.  Are Epithelial Ovarian Cancers of the Mesenchymal Subtype Actually Intraperitoneal Metastases to the Ovary?

Authors:  Ye Hu; Barbie Taylor-Harding; Yael Raz; Marcela Haro; Maria Sol Recouvreux; Enes Taylan; Jenny Lester; Joshua Millstein; Ann E Walts; Beth Y Karlan; Sandra Orsulic
Journal:  Front Cell Dev Biol       Date:  2020-07-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.